Page 26 - 14_Atti_SIN_SNO_2022_flip
P. 26

Proceedings SNO                                                   “Percorsi clinici in Neuroscienze”



                                                                                          Figure 1. Brain MRI
                                                                                          showing bilateral hyper-
                                                                                          intensity of medial ol-
                                                                                          factory striae on  T2
                                                                                          3D FLAIR.























                DISCUSSION

             This report shows an unprecedented cortical hyperin-
             tensity in the medial olfactory striae on 3D FLAIR
             MRI in a patient with persistent cacosmia and phan-
             tosmia 14 months after SARS-Cov2 infection, sup-
             porting the hypothesis of SARS-Cov2 neurotropic
             propagation through the olfactory system.
             Interestingly, the treatment with Carbamazepine
             seemed to reduce the phantosmia episodes, reinforc-
             ing the hypothesis of a focal structural alteration in-
             volving the olfactory striae. Collaterally to the olfac-
             tory dysfunction, the patient also developed a new
             onset of mood and cognitive impairment which could
             suggest a more complex involvement of CNS after
             SARS-Cov2 infection. Patients with persistent olfac-  3.  Aragão MFVV, Leal MC, Cartaxo Filho OQ, Fonseca
             tory impairment should be carefully monitored for   TM,  Valença MM.  Anosmia in COVID-19 associated
             long term neurological sequelae.                    with injury to the olfactory bulbs evident on MRI. AJNR
                                                                 Am J Neuroradiol 2020; 41 (9): 1703-1706.
                                                              4.  Tsivgoulis G, Fragkou PC, Lachanis S, Palaiodimou L,
                REFERENCES                                       Lambadiari  V, Papathanasiou M, Sfikakis PP,  Voum-
                                                                 vourakis KI, Tsiodras S. Olfactory bulb and mucosa ab-
             1.  Desai M, Oppenheimer J. The Importance of considering  normalities in persistent COVID-19-induced anosmia: a
                olfactory dysfunction during the COVID-19 pandemic  magnetic resonance imaging study. Eur J Neurol 2021;
                and in clinical practice. J Allergy Clin Immunol Pract  28(1): e6-e8.
                2021; 9 (1): 7-12.                            5.  Xydakis MS, Albers MW, Holbrook EH, Lyon DM, Shih
             2.  Politi LS, Salsano E, Grimaldi M. Magnetic resonance  RY, Frasnelli JA, Pagenstecher A, Kupke A, Enquist LW,
                imaging alteration of the brain in a patient with coron-  Perlman S. Post-viral effects of COVID-19 in the olfacto-
                avirus disease 2019 (COVID-19) and anosmia. JAMA  ry system and their implications. Lancet Neurol 2021; 20
                Neurol 2020; 77 (8): 1028-1029.                  (9): 753-761.









                                                          - 24 -
   21   22   23   24   25   26   27   28   29   30   31